NJ MPJE study plan

Outline the NJ Board of Pharmacy licensure and registration pathways for pharmacists, pharmacy interns, pharmacy technicians, and each class of pharmacy permit, including renewal cycles and continuing education obligations.

Differentiate the NJ pharmacy permit classes and list the physical facility, equipment, and security standards required for each.

Map federal FDCA prescription requirements (prescription-drug status, required label content, refill limits, oral versus written orders) against the parallel NJ requirements in a side-by-side format.

Identify which personnel and facility duties may be delegated to a certified pharmacy technician and which are reserved to the pharmacist.

Sequence NJ CDS Schedules I through V and flag every substance or class that NJ places differently than the federal schedules.

State the NJ statutory limits on initial and subsequent prescribing of controlled dangerous substances, including opioid quantity limits and any exception categories.

Reproduce the required elements of a valid NJ CDS prescription and list the circumstances that permit an oral, faxed, or electronic order in place of a written form.

Calculate the maximum lawful quantity that may be dispensed for a set of sample prescriptions drawn from different schedules.

Distinguish the NJ prescription monitoring Program query triggers that apply to pharmacists dispensing controlled dangerous substances.

Assign the correct DEA registration category to each activity described in a set of practice scenarios, including separate registrations for each principal place of business.

Trace the controlled substance ordering cycle from the DEA Form 222 and CSOS order through the receiving invoice, power of attorney designation, and record filing.

Apply federal recordkeeping and inventory rules, including the biennial inventory, the two-year retention requirement, and the security and storage standards for each schedule.

Contrast federal and NJ requirements wherever the state imposes a stricter retention, inventory, or security obligation.

List the reporting duties that follow a theft or significant loss of controlled substances.

Apply the required label content rules to a set of sample dispensing scenarios and identify every missing or incorrect element.

Determine the counseling obligation for each scenario and identify the circumstances under which a patient may decline counseling and how that declination is documented.

Evaluate refill authorization, dispensing interval, and partial-fill questions against both federal and NJ requirements.

Assess auxiliary labeling and safety information obligations for high-alert and look-alike/sound-alike products.

Apply the NJ drug product selection rules to sample prescriptions, including bioequivalence rating, prescriber and patient consent, and the recordkeeping and label notation that follow a substitution.

Differentiate generic substitution from therapeutic interchange and state who is authorized to approve each in community and institutional settings.

Classify a set of compounding preparations as sterile or non-sterile and match each to the applicable USP general chapter standard and its environmental and testing requirements.

List the facility, environmental monitoring, garbing, and personnel competency requirements for sterile compounding and identify the NJ Board oversight and inspection expectations.

Identify which compounded preparations may not be prepared or dispensed because of a copy of a commercially available product or an outsourcing facility restriction.

Build a workflow that routes a medication error or adverse event to the correct internal, Board of Pharmacy, and FDA MedWatch reporting channel within the correct timeframe.

Describe the pharmacist registration and query obligations under the NJ prescription monitoring program and identify the red-flag patterns that require follow-up action.

State the pharmacist immunization authority in NJ, including permissible vaccines and age ranges, protocol or prescriber order requirements, training and certification prerequisites, and immunization registry reporting.

Outline the elements a collaborative practice agreement must contain and identify which expanded scope activities require a separate credential or Board approval.

Execute a prescription transfer for both non-controlled and controlled substances, applying the one-time transfer limit and documenting the required elements at both pharmacies.

Apply the retention periods and retrieval expectations for prescriptions, invoices, inventories, and counseling records, and build a table that separates federal from NJ requirements.

Process a drug recall and a return-to-stock or return-to-wholesaler scenario through the correct quarantine, documentation, and reverse distributor steps.

Evaluate pricing and business practice scenarios, including prescription pricing transparency, dispensing fee disclosure, and prohibitions on improper inducements.

Distinguish returnable from non-returnable drug product based on storage conditions and chain-of-custody documentation.

Complete two full-length timed practice examinations under exam conditions and record the score for each domain.

Re-drill every missed item from weeks 1 through 7 and rewrite each weak rule as a single accurate sentence.

Rebuild condensed summary sheets for the three lowest-scoring domains.

Recite from memory the NJ-specific numbers most likely to be tested, including quantity limits, retention periods, and reporting timeframes.